Biovie (BIVI) Equity Average: 2013-2025
Historic Equity Average for Biovie (BIVI) over the last 1 years, with Mar 2025 value amounting to $22.9 million.
- Biovie's Equity Average was N/A to $22.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $22.9 million, marking a year-over-year change of. This contributed to the annual value of $17.3 million for FY2025, which is 11.90% up from last year.
- As of Q1 2025, Biovie's Equity Average stood at $22.9 million, which was up 20.40% from $19.0 million recorded in Q4 2024.
- In the past 5 years, Biovie's Equity Average ranged from a high of $23.9 million in Q1 2023 and a low of $12.2 million during Q1 2021.
- Moreover, its 3-year median value for Equity Average was $22.9 million (2025), whereas its average is $21.9 million.
- Per our database at Business Quant, Biovie's Equity Average surged by 657.70% in 2021 and then declined by 11.76% in 2022.
- Quarterly analysis of 5 years shows Biovie's Equity Average stood at $18.1 million in 2021, then fell by 11.76% to $16.0 million in 2022, then spiked by 83.65% to $23.9 million in 2023, then reached $19.0 million in 2024, then reached $22.9 million in 2025.
- Its Equity Average was $22.9 million in Q1 2025, compared to $19.0 million in Q4 2024 and $23.9 million in Q1 2023.